A DLL1-culture system to propagate murine patrolling monocytes from bone marrow progenitors
Open Access
- 22 July 2026
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 118 (8)
Abstract
Patrolling monocytes (pMos) scavenge debris from vessel walls and mediate antibody-dependent cellular phagocytosis, making them attractive cell therapy candidates for cancer, atherosclerosis, and Alzheimer's disease. However, methods to generate pMos for cell therapy are not available. To address this, we developed a 2-step procedure to produce pMos in vitro from murine bone marrow (BM). First, myeloid progenitors were expanded and enriched from BM using cytokines for 4 d. Second, expanded progenitors were differentiated into pMos on delta-like ligand 1 (DLL1)-expressing monolayers for 8 d. We confirmed that in vitro grown pMos expressed the transcription factor Nr4a1 (Nur77) and other canonical pMos surface proteins, and depended on Notch signaling for their development. RNA-sequencing revealed that in vitro pMos expressed hallmark pMos genes, including Cx3cr1, Itgax (CD11c), CD43, Fcγr4, and Cd274 (PD-L1), and their gene signatures clustered closely with in vivo blood and BM pMos. Transcriptomic and phenotypic analyses further demonstrated that in vitro pMos were distinct from classical BM macrophages. Phagocytosis assays demonstrated the function of in vitro pMos in cancer cell uptake. Adoptive transfer studies demonstrated that in vitro pMos persisted within the circulation and lung vasculature during the early post-transfer period compared with BM-derived macrophages, consistent with the vascular-patrolling properties of pMos. Adoptive transfer of pMos reduced lung tumor burden in a metastatic model, supporting an anti-tumoral role for pMos and their ability to mediate immune surveillance in vivo. These findings demonstrate that the DLL1 culture system allows for propagation of functional pMos, enabling studies of pMos biology and their therapeutic potential.Keywords
Funding Information
- Canadian Institutes of Health Research (453515)
- Canadian Institutes of Health Research (367170)
- Alzheimer's Society of Canada
This publication has 48 references indexed in Scilit:
- Vascular‐Associated Mononuclear Phagocytes: First‐Line Soldiers Ambushing MetastasisBioEssays, 2024
- Triggering of NOD2 Receptor Converts Inflammatory Ly6Chigh into Ly6Clow Monocytes with Patrolling PropertiesCell Reports, 2017
- Genomic Characterization of Murine Monocytes Reveals C/EBPβ Transcription Factor Dependence of Ly6C − CellsImmunity, 2017
- Deleting an Nr4a1 Super-Enhancer Subdomain Ablates Ly6C low Monocytes while Preserving Macrophage Gene FunctionImmunity, 2016
- Molecular control of monocyte developmentCellular Immunology, 2014
- Real-Time In Vivo Imaging Reveals the Ability of Monocytes to Clear Vascular Amyloid BetaCell Reports, 2013
- Nr4a1-Dependent Ly6Clow Monocytes Monitor Endothelial Cells and Orchestrate Their DisposalCell, 2013
- Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under HomeostasisImmunity, 2013
- Monocyte Subsets Responsible for Immunoglobulin G-Dependent Effector Functions In VivoImmunity, 2011
- Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 ReceptorsImmunity, 2010